NCT06537375

Brief Summary

Ketamine has been shown to have a certain efficiency in chronic pain syndromes. However, it is still not clearly known what is its efficiency and how ketamine is used in real world patients. In this retrospective study, all patients treated with ketamine for chronic pain in our hospital will be reviewed. Patients demographics, pain syndromes as well as outcome criteria will be collected to describe the use of ketamine in pain syndromes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2025

Completed
Last Updated

February 25, 2025

Status Verified

August 1, 2024

Enrollment Period

7 months

First QC Date

August 1, 2024

Last Update Submit

February 24, 2025

Conditions

Pain, IntractablePain, ChronicPain SyndromePain Measurement

Outcome Measures

Primary Outcomes (3)

  • Patient satisfaction

    A scale (good-medium-no effect) of the efficacity of ketamine on their pain syndrome

    6 month

  • DN4

    Neuropathic pain scale 4

    6 month

  • VAS

    Visual analog scale of the pain intensity

    6 month

Secondary Outcomes (1)

  • Concomitant pain medications

    6 month

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who received ketamine as treatment for a pain syndrome during january 2010 until june 2024 at Erasme University Hospital

You may qualify if:

  • \- All patients who received ketamine as treatment for a pain syndrome during january 2010 until june 2024 at Erasme University Hospital

You may not qualify if:

  • Age \< 18 years
  • Patients who expressed their opposition to the use of their medical data
  • incomplete medical chart

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Universitaire de Bruxelles - Hôpital erasme

Brussels, 1070, Belgium

Location

MeSH Terms

Conditions

Pain, IntractableChronic PainSomatoform Disorders

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2024

First Posted

August 5, 2024

Study Start

August 1, 2024

Primary Completion

February 20, 2025

Study Completion

February 20, 2025

Last Updated

February 25, 2025

Record last verified: 2024-08

Locations

BE(1)